BEIJING, China (AFP) — Phase 3 trials of a Sinopharm coronavirus vaccine found it was 79 percent effective, the Chinese pharma giant said Wednesday, lower than rival jabs developed by Pfizer-BioNTech and Moderna but a potential breakthrough in the battle to stem the pandemic in Asia. China has been racing against the West to develop its own Covid-19 vaccines, with five already in large-scale Phase 3 clinical trials. But Wednesday’s announced was the first […]